ReviewCureus2023

The Roles of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists and Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors in Decreasing the Occurrence of Adverse Cardiorenal Events in Patients With Type 2 Diabetes.

Dalia Shami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.